NBCNews.com |
Ethicist: Why a New Alzheimer's Drug Isn't A No-Brainer
NBCNews.com In a very early stage safety test aducanumab slowed the cognitive decline and dementia associated with Alzheimer's in people. On the Mini Mental Status Exam, a widely used measure of cognitive function, people at risk of Alzheimer's who got a placebo … Alzheimer's debate revived as Biogen's drug trial advances Potential Alzheimer's drug further backs protein hypothesis |
Tag: frontotemporal dementia
‘MIND’ Your Diet, and Protect Against Alzheimer’s – Live Science
Live Science |
'MIND' Your Diet, and Protect Against Alzheimer's
Live Science Alzheimer's disease, the most common form of dementia, affects more than 40 million people globally, according to Alzheimer's Disease International. Among developed nations, the prevalence rates tend to be highest in North America and northern Europe … The MIND diet provides some good news in the fight against Alzheimer's New MIND diet lowers risk of developing Alzheimer's Disease by 53 percent! Food for the mind |
Alzheimer’s Debate Revived Even as Biogen’s Drug Trial Advances – Bloomberg
Bloomberg |
Alzheimer's Debate Revived Even as Biogen's Drug Trial Advances
Bloomberg The researchers examined more than 3,600 brains from patients who died at different stages of dementia, with Alzheimer's confirmed in almost 1,400. Measuring amyloid and tau in the brains at various stages of disease progression allowed them to … Alzheimer's: Tau, Not Amyloid, Is The Primary Driver Study: Progression of dysfunctional tau protein drives cognitive decline in … Mayo Clinic Study of Thousands of Brains Reveals Tau as Driver of Alzheimer's … |
5 Documentaries About Memory Loss, Dementia, and Alzheimers – Newsmax
|
5 Documentaries About Memory Loss, Dementia, and Alzheimers
Newsmax Millions of Americans will experience some form of memory loss, dementia and Alzheimer's, as the debilitating and fatal brain disorder places incredible strain on everyone involved. Alzheimer's may affect as many as 5 million United States citizens … |
Business in fight against dementia – The Australian Financial Review
The Australian Financial Review |
Business in fight against dementia
The Australian Financial Review Genworth Mortgage Insurance chairman Richard Grellman has first-hand experience of the high levels of care and support needed for people affected with dementia. His wife Suellen was diagnosed four years ago with advanced young-onset Alzheimer's … Hopeful news from — and for — Alzheimer's researchers Public Release: 23-Mar-2015 Research identifies novel steps in dementia … |
Alzheimer’s drug trial shows promising early results – The Guardian
The Guardian |
Alzheimer's drug trial shows promising early results
The Guardian But the dearth of drugs to halt or even slow the progress of dementia – of which Alzheimer's is the most common type – means that any positive results will be greeted with enthusiasm. In the trial, conducted primarily to ensure the drug was safe and … Dementia Silver Bullet? New Drug Might Slow Alzheimer's Biogen's Alzheimer's drug shows early promise Biogen's Alzheimer's drug slows mental decline in early study |
Dementia Silver Bullet? New Drug Might Slow Alzheimer’s – NBC Bay Area
NBC Bay Area |
Dementia Silver Bullet? New Drug Might Slow Alzheimer's
NBC Bay Area There is no cure for Alzheimer's disease, the most common form of dementia. About 35 million people worldwide have Alzheimer's, and current treatments only temporarily ease symptoms. The causes of the disease are still not very well understood and … Alzheimer's drug trial shows promising early results Biogen drug tackles Alzheimer's brain protein Biogen's Alzheimer's drug slows mental decline in early study |
Biogen Reports Its Alzheimer’s Drug Sharply Slowed Cognitive Decline – New York Times
New York Times |
Biogen Reports Its Alzheimer's Drug Sharply Slowed Cognitive Decline
New York Times Aducanumab, which until now has been called BIIB037, is designed to get rid of amyloid plaque in the brain, which is widely believed to be a cause of the dementia in Alzheimer's disease. However, other drugs designed to prevent or eliminate plaque have … Biogen's Alzheimer's drug slows mental decline in early study Dementia Silver Bullet? New Drug Might Slow Alzheimer's Biogen's Alzheimer's drug shows early promise |
Alzheimer’s/Dementia Caregiver Support Group to meet – NJ.com
|
Alzheimer's/Dementia Caregiver Support Group to meet
NJ.com ELIZABETH — Jewish Family Service of Central NJ, a non-sectarian health and social service agency, will host an Alzheimer's/Dementia Caregiver Support Group on Thursday, April 2, from 1 to 3 p.m.. The group is free and open to Alzheimer's/Dementia … |
Alzheimer’s test: Mayo clinic finds easy test to detect dementia – Digital Journal
Digital Journal |
Alzheimer's test: Mayo clinic finds easy test to detect dementia
Digital Journal Testing for Alzheimer's Disease is an expensive and complicated proposition at the moment but the Mayo Clinic may have a solution. They've released a study this week on a three-part test for dementia that could be done in your physician's office. New test will help doctors identify if you are at risk of memory problems Measuring dementia risk: Now there's a number for that, too Can This 3-Step Test Predict Alzheimer's? |